Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

NCT05776524 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Metastatic Adenocarcinoma

Interventions

DRUG: Nab paclitaxel
DRUG: Gemcitabine
DEVICE: TheraBionic

Sponsor

THERABIONIC INC.

Collaborators

[object Object]